NO20054662D0 - Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre - Google Patents

Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre

Info

Publication number: NO20054662D0
Authority: NO; Norway
Prior art keywords: fluoroaniline; chloro; methyl; pharmaceutical composition; phenylacetic acid
Prior art date: 2003-03-12

Application number

NO20054662A

Other languages

English (en)

Other versions

NO20054662L (no

Inventor

Maha Y Khaled

Patrick Forenzo

Barbara Wang

Joseph Lawrence Zielinski

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-12

Filing date

2005-10-11

Publication date

2005-10-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32990870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054662(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-10-11 Application filed by Novartis Ag filed Critical Novartis Ag

2005-10-11 Publication of NO20054662D0 publication Critical patent/NO20054662D0/no

2005-12-05 Publication of NO20054662L publication Critical patent/NO20054662L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20054662A 2003-03-12 2005-10-11 Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre NO20054662L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45414503P	2003-03-12	2003-03-12
PCT/EP2004/002528 WO2004080451A1 (en)	2003-03-12	2004-03-11	Pharmaceutical composition comprising 5-methyl-2-2’-(chloro-6’-fluoroanilino) phe nylacetic acid

Publications (2)

Publication Number	Publication Date
NO20054662D0 true NO20054662D0 (no)	2005-10-11
NO20054662L NO20054662L (no)	2005-12-05

Family

ID=32990870

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054662A NO20054662L (no)	2003-03-12	2005-10-11	Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre

Country Status (29)

Country	Link
US (2)	US20060094787A1 (no)
EP (1)	EP1603550B1 (no)
JP (1)	JP4580921B2 (no)
KR (1)	KR20050109077A (no)
CN (1)	CN100345536C (no)
AR (1)	AR043536A1 (no)
AT (1)	ATE418332T1 (no)
AU (1)	AU2004218921B2 (no)
BR (1)	BRPI0408270A (no)
CA (1)	CA2518393A1 (no)
CL (1)	CL2004000496A1 (no)
DE (1)	DE602004018622D1 (no)
EC (1)	ECSP055998A (no)
ES (1)	ES2318277T3 (no)
HR (1)	HRP20050787A2 (no)
IL (1)	IL170518A (no)
IS (1)	IS2658B (no)
MA (1)	MA27670A1 (no)
MX (1)	MXPA05009686A (no)
MY (1)	MY139455A (no)
NO (1)	NO20054662L (no)
NZ (1)	NZ542218A (no)
PE (1)	PE20041063A1 (no)
PT (1)	PT1603550E (no)
RU (1)	RU2363462C2 (no)
TN (1)	TNSN05222A1 (no)
TW (1)	TWI327913B (no)
WO (1)	WO2004080451A1 (no)
ZA (1)	ZA200506750B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005037266A1 (en) *	2003-10-08	2005-04-28	Novartis Ag	Pharmaceutical composition comprising 5-methyl-2-(2’-chloro-6’-fluoroanilino)phenylacetic acid
KR100900915B1 (ko) *	2007-05-07	2009-06-05	이연제약주식회사	메게스트롤 아세테이트를 함유하는 현탁액 제제 및 이의제조방법
KR20100087002A (ko) *	2007-11-12	2010-08-02	노파르티스 아게	발사르탄을 포함하는 액체 조성물
EP2926810A1 (en) *	2014-03-31	2015-10-07	Sanovel Ilac Sanayi ve Ticaret A.S.	Oral liquid pharmaceutical formulations of loxoprofen
CA3027434A1 (en) *	2016-06-16	2017-12-21	Cutispharma, Inc.	Composition and method for proton pump inhibitor suspension
CA3036356A1 (en) *	2016-09-09	2018-03-15	Cutispharma, Inc.	Suspensions and diluents for metronidazole and baclofen
US11433074B2 (en)	2017-06-22	2022-09-06	Triact Therapeutics, Inc.	Methods of treating glioblastoma
EP3687501A4 (en) *	2017-09-29	2021-06-23	Triact Therapeutics, Inc.	INIPARIB FORMS AND USES THEREOF
US10751333B1 (en) *	2019-07-16	2020-08-25	Cutispharma, Inc.	Compositions and kits for omeprazole suspension
US11633478B2 (en)	2019-07-16	2023-04-25	Azurity Pharmaceuticals, Inc.	Compositions and kits for Omeprazole suspension

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5112604A (en) *	1989-09-01	1992-05-12	Riker Laboratories, Inc.	Oral suspension formulation
US5840768A (en) *	1997-06-04	1998-11-24	Fmc Corporation	MCC: alginate pharmaceutical suspensions
US6103260A (en) *	1997-07-17	2000-08-15	Mcneil-Ppc, Inc.	Simethicone/anhydrous calcium phosphate compositions
CO4960662A1 (es) *	1997-08-28	2000-09-25	Novartis Ag	Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
US20020028794A1 (en) *	2000-07-21	2002-03-07	Brubaker Greg Allen	Megestrol acetate suspension
AR030630A1 (es) *	2000-09-11	2003-08-27	Novartis Ag	Composiciones farmaceuticas
CA2472585A1 (en) *	2002-01-07	2003-07-17	Pharmacia Corporation	Drug mixture with enhanced dissolution rate
EP1497268A4 (en) *	2002-04-05	2006-01-18	Nitromed Inc	NITROGEN OXIDE DISPENSER, COMPOSITIONS AND METHOD OF USE

2004
- 2004-03-09 TW TW093106228A patent/TWI327913B/zh not_active IP Right Cessation
- 2004-03-10 AR ARP040100769A patent/AR043536A1/es not_active Application Discontinuation
- 2004-03-10 PE PE2004000262A patent/PE20041063A1/es not_active Application Discontinuation
- 2004-03-11 MX MXPA05009686A patent/MXPA05009686A/es active IP Right Grant
- 2004-03-11 WO PCT/EP2004/002528 patent/WO2004080451A1/en active IP Right Grant
- 2004-03-11 BR BRPI0408270-2A patent/BRPI0408270A/pt not_active IP Right Cessation
- 2004-03-11 CN CNB2004800056641A patent/CN100345536C/zh not_active Expired - Fee Related
- 2004-03-11 AT AT04719398T patent/ATE418332T1/de active
- 2004-03-11 RU RU2005131310/15A patent/RU2363462C2/ru not_active IP Right Cessation
- 2004-03-11 JP JP2006504648A patent/JP4580921B2/ja not_active Expired - Fee Related
- 2004-03-11 CA CA002518393A patent/CA2518393A1/en not_active Abandoned
- 2004-03-11 NZ NZ542218A patent/NZ542218A/en not_active IP Right Cessation
- 2004-03-11 DE DE602004018622T patent/DE602004018622D1/de not_active Expired - Lifetime
- 2004-03-11 KR KR1020057016860A patent/KR20050109077A/ko not_active Ceased
- 2004-03-11 MY MYPI20040851A patent/MY139455A/en unknown
- 2004-03-11 EP EP04719398A patent/EP1603550B1/en not_active Expired - Lifetime
- 2004-03-11 AU AU2004218921A patent/AU2004218921B2/en not_active Ceased
- 2004-03-11 ES ES04719398T patent/ES2318277T3/es not_active Expired - Lifetime
- 2004-03-11 HR HR20050787A patent/HRP20050787A2/xx not_active Application Discontinuation
- 2004-03-11 CL CL200400496A patent/CL2004000496A1/es unknown
- 2004-03-11 US US10/549,249 patent/US20060094787A1/en not_active Abandoned
- 2004-03-11 PT PT04719398T patent/PT1603550E/pt unknown
2005
- 2005-08-23 ZA ZA200506750A patent/ZA200506750B/xx unknown
- 2005-08-25 IL IL170518A patent/IL170518A/en not_active IP Right Cessation
- 2005-09-02 EC EC2005005998A patent/ECSP055998A/es unknown
- 2005-09-09 TN TNP2005000222A patent/TNSN05222A1/en unknown
- 2005-09-28 IS IS8049A patent/IS2658B/is unknown
- 2005-09-30 MA MA28525A patent/MA27670A1/fr unknown
- 2005-10-11 NO NO20054662A patent/NO20054662L/no not_active Application Discontinuation
2008
- 2008-10-07 US US12/287,231 patent/US20090048344A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CL2004000496A1 (es)	2005-01-14
DE602004018622D1 (de)	2009-02-05
IL170518A (en)	2010-11-30
TNSN05222A1 (en)	2007-06-11
EP1603550A1 (en)	2005-12-14
ES2318277T3 (es)	2009-05-01
IS2658B (is)	2010-08-15
EP1603550B1 (en)	2008-12-24
TWI327913B (en)	2010-08-01
ZA200506750B (en)	2007-02-28
AU2004218921B2 (en)	2007-05-17
ATE418332T1 (de)	2009-01-15
PT1603550E (pt)	2009-03-20
RU2363462C2 (ru)	2009-08-10
HK1086492A1 (en)	2006-09-22
BRPI0408270A (pt)	2006-03-07
AR043536A1 (es)	2005-08-03
NZ542218A (en)	2009-01-31
ECSP055998A (es)	2006-01-27
JP4580921B2 (ja)	2010-11-17
MXPA05009686A (es)	2005-10-20
JP2006519811A (ja)	2006-08-31
NO20054662L (no)	2005-12-05
RU2005131310A (ru)	2006-05-10
US20060094787A1 (en)	2006-05-04
AU2004218921A1 (en)	2004-09-23
US20090048344A1 (en)	2009-02-19
PE20041063A1 (es)	2005-03-07
IS8049A (is)	2005-09-28
CN1756541A (zh)	2006-04-05
HRP20050787A2 (en)	2006-12-31
MY139455A (en)	2009-10-30
CA2518393A1 (en)	2004-09-23
MA27670A1 (fr)	2005-12-01
WO2004080451A1 (en)	2004-09-23
TW200505429A (en)	2005-02-16
CN100345536C (zh)	2007-10-31
KR20050109077A (ko)	2005-11-17

Publication	Publication Date	Title
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
DK1453517T3 (da)	2006-06-19	Farmaceutiske formuleringer med platinderivat
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
PL367180A1 (pl)	2005-02-21	Trwała kompozycja farmaceutyczna
PT1467724E (pt)	2006-08-31	Composicao farmaceutica orodispersavel de agomelatina
IS7571A (is)	2004-11-29	Ný lífeðlisfræðilega virk efni
DE602004016967D1 (de)	2008-11-20	Flüssige pharmazeutische palonosetronformulierungen
SK4326U (sk)	2005-12-01	Farmaceutická kompozícia s predĺženým uvoľňovaním
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
FI20022128A0 (fi)	2002-12-03	Farmaseuttinen koostumus
DE60218213D1 (de)	2007-03-29	Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
EP1611147A4 (en)	2007-10-17	6 "amino-6" -DEOXYGALACTOSYLCERAMIDE
NO20054662D0 (no)	2005-10-11	Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
NO20044164L (no)	2004-09-30	Farmasoytiske sammensetninger
DK1653963T3 (da)	2007-04-10	Nasal farmaceutisk sammensætning piribedil
DE112004001429D2 (de)	2006-04-13	Pharmazeutischer Wirkstoff
DE602004030921D1 (de)	2011-02-17	Pharmazeutische zusammensetzung
DOP2002000508A (es)	2003-06-15	Composición farmaceutica
SE0201660D0 (sv)	2002-05-31	Pharmaceutical formulation
SE0200449D0 (sv)	2002-02-13	Pharmaceutical formulation

Legal Events

Date	Code	Title	Description
2012-10-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application